根据和铂医药控股有限公司（股票代码：02142）于2026年4月9日发布的截至2026年3月31日的月报表显示，公司法定股本维持在20,000,000,000股，面值为每股0.000025美元，法定股本总额500,000美元，较上月无变化。
报告期末，公司已发行普通股（不含库存股）数量为869,850,522股，库存股数量为25,937,000股，总股本为895,787,522股。与上月相比，普通股数量增加259,000股，主要源于“首次公开发售后股份奖励计划”授予的股份。另有一项于2024年6月6日产生的购回股份406,000股尚未注销，但本月内无新增购回或注销行为。
公司披露，报告期末共有39,033,100份股份期权未行使，并无新增授出、行使或失效情况。公司确认已达到在香港联交所的最低公众持股量要求。该报告由公司执行董事王劲松签署，并确认所有股份变动已遵循相关上市规则及法定程序。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.